Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more
Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a global phase III clinical... Read more
What is Glivec? Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, receptor tyrosine... Read more
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide ligand binding... Read more
Singapore: Assistant Professor (Dr) Robert H I Andtbacka presented a summary of his ongoing study with Viralytics' Cavatak clinical trial... Read more
Singapore: Europe's CellSeed has withdrawn its application for a centralized marketing authorization for the medicine OraNera (autologous... Read more
Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials in patients with... Read more
Singapore: Boehringer Ingelheim and Eli Lilly have initiated phase IIIb trial to evaluate the glycaemic efficacy and safety of linagliptin... Read more
Singapore: Taiwan Liposome Company's multi-mechanistic anti-cancer new chemical entity Lipotecan has been accepted into the "Green Path"... Read more
Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to multiple drugs could... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
